Skip to main content
Premium Trial:

Request an Annual Quote

Eureka Genomics, Baylor Ink Research, Commercialization Deal

Premium

Eureka Genomics and Baylor Research Institute, the research arm of the Baylor Health Care System, said this week that they will work together to understand the causes of colorectal cancer, potentially leading to better prevention, management, and treatment techniques.

Under the agreement, Eureka will use its proprietary bioinformatics system to provide data analysis while BRI will contribute expertise and clinical resources related to colorectal cancer, and intellectual property regarding the JC virus — a potential causative agent in the disease.

Terms of the agreement call for the partners to jointly own any intellectual property relating to the biology or etiology of cancer arising from their collaboration and share revenues from commercialization of potential diagnostics and treatments.

The partners hope to confirm suspicions, based on prior research at Baylor, that the JC virus is involved in colorectal cancer, as well as identify other microbial or genetic factors.

"This collaboration represents an opportunity to use next generation DNA sequencing techniques — or deep sequencing — to look for non-human DNA sequences in colon tumors,” Richard Boland, principal BRI investigator and chief of the gastroenterology division at Baylor University Medical Center, said in a statement. "It will help us know how many copies of the virus are present in tumor tissues, whether the virus is integrated or, as we think, exists as an independent 'parasite' in the nucleus."

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.